nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—PLA2G4A—Orlistat—obesity	0.459	1	CbGbCtD
Fluocinolone Acetonide—NR3C1—obesity	0.327	1	CbGaD
Fluocinolone Acetonide—SERPINA6—hindbrain—obesity	0.00304	0.118	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—respiratory system—obesity	0.00186	0.0721	CbGeAlD
Fluocinolone Acetonide—SERPINA6—respiratory system—obesity	0.00186	0.0718	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—adrenal cortex—obesity	0.00156	0.0605	CbGeAlD
Fluocinolone Acetonide—Ear infection—Orlistat—obesity	0.00151	0.014	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—cardiovascular system—obesity	0.00143	0.0552	CbGeAlD
Fluocinolone Acetonide—Intraocular pressure increased—Sibutramine—obesity	0.00141	0.0131	CcSEcCtD
Fluocinolone Acetonide—NR3C1—hindbrain—obesity	0.00133	0.0515	CbGeAlD
Fluocinolone Acetonide—Ear infection—Bupropion—obesity	0.00128	0.0118	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—pituitary gland—obesity	0.00126	0.0489	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—adipose tissue—obesity	0.00126	0.0487	CbGeAlD
Fluocinolone Acetonide—SERPINA6—pituitary gland—obesity	0.00126	0.0487	CbGeAlD
Fluocinolone Acetonide—Skin irritation—Bupropion—obesity	0.00125	0.0116	CcSEcCtD
Fluocinolone Acetonide—Impaired healing—Bupropion—obesity	0.00125	0.0116	CcSEcCtD
Fluocinolone Acetonide—Conjunctival oedema—Topiramate—obesity	0.00125	0.0115	CcSEcCtD
Fluocinolone Acetonide—Intraocular pressure increased—Bupropion—obesity	0.00123	0.0114	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—adrenal gland—obesity	0.00113	0.0437	CbGeAlD
Fluocinolone Acetonide—SERPINA6—adrenal gland—obesity	0.00112	0.0435	CbGeAlD
Fluocinolone Acetonide—Photopsia—Topiramate—obesity	0.00109	0.01	CcSEcCtD
Fluocinolone Acetonide—Dizziness postural—Topiramate—obesity	0.000989	0.00913	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—endocrine gland—obesity	0.000979	0.0379	CbGeAlD
Fluocinolone Acetonide—SERPINA6—endocrine gland—obesity	0.000975	0.0377	CbGeAlD
Fluocinolone Acetonide—Hypertrichosis—Topiramate—obesity	0.000909	0.00839	CcSEcCtD
Fluocinolone Acetonide—SERPINA6—liver—obesity	0.000879	0.034	CbGeAlD
Fluocinolone Acetonide—Folliculitis—Bupropion—obesity	0.000863	0.00796	CcSEcCtD
Fluocinolone Acetonide—NR3C1—islet of Langerhans—obesity	0.000861	0.0333	CbGeAlD
Fluocinolone Acetonide—Mania—Sibutramine—obesity	0.000856	0.00789	CcSEcCtD
Fluocinolone Acetonide—Glaucoma—Sibutramine—obesity	0.000826	0.00762	CcSEcCtD
Fluocinolone Acetonide—NR3C1—respiratory system—obesity	0.000813	0.0314	CbGeAlD
Fluocinolone Acetonide—Otitis media—Sibutramine—obesity	0.000799	0.00737	CcSEcCtD
Fluocinolone Acetonide—Abscess—Sibutramine—obesity	0.000787	0.00726	CcSEcCtD
Fluocinolone Acetonide—Intraocular pressure increased—Topiramate—obesity	0.000786	0.00725	CcSEcCtD
Fluocinolone Acetonide—Rash pustular—Sibutramine—obesity	0.00078	0.0072	CcSEcCtD
Fluocinolone Acetonide—Mania—Bupropion—obesity	0.000746	0.00688	CcSEcCtD
Fluocinolone Acetonide—Endophthalmitis—Topiramate—obesity	0.000726	0.0067	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Phendimetrazine—obesity	0.000709	0.00654	CcSEcCtD
Fluocinolone Acetonide—Eyelid oedema—Topiramate—obesity	0.000685	0.00632	CcSEcCtD
Fluocinolone Acetonide—NR3C1—adrenal cortex—obesity	0.000682	0.0264	CbGeAlD
Fluocinolone Acetonide—Herpes simplex—Sibutramine—obesity	0.000675	0.00623	CcSEcCtD
Fluocinolone Acetonide—Rhinorrhoea—Bupropion—obesity	0.00067	0.00618	CcSEcCtD
Fluocinolone Acetonide—Cataract—Sibutramine—obesity	0.000654	0.00603	CcSEcCtD
Fluocinolone Acetonide—Neck pain—Sibutramine—obesity	0.00063	0.00581	CcSEcCtD
Fluocinolone Acetonide—NR3C1—cardiovascular system—obesity	0.000622	0.0241	CbGeAlD
Fluocinolone Acetonide—Dermatitis contact—Sibutramine—obesity	0.000615	0.00567	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Phenylpropanolamine—obesity	0.000606	0.00559	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Methamphetamine—obesity	0.000603	0.00557	CcSEcCtD
Fluocinolone Acetonide—Lacrimation increased—Bupropion—obesity	0.000589	0.00543	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Benzphetamine—obesity	0.000582	0.00537	CcSEcCtD
Fluocinolone Acetonide—Visual acuity reduced—Topiramate—obesity	0.000581	0.00536	CcSEcCtD
Fluocinolone Acetonide—Dry eye—Sibutramine—obesity	0.000575	0.0053	CcSEcCtD
Fluocinolone Acetonide—NR3C1—pituitary gland—obesity	0.000551	0.0213	CbGeAlD
Fluocinolone Acetonide—Neck pain—Bupropion—obesity	0.000549	0.00507	CcSEcCtD
Fluocinolone Acetonide—NR3C1—adipose tissue—obesity	0.000549	0.0212	CbGeAlD
Fluocinolone Acetonide—Alopecia—Diethylpropion—obesity	0.000543	0.00501	CcSEcCtD
Fluocinolone Acetonide—Erythema—Diethylpropion—obesity	0.000535	0.00494	CcSEcCtD
Fluocinolone Acetonide—Ear pain—Sibutramine—obesity	0.000529	0.00489	CcSEcCtD
Fluocinolone Acetonide—Wheezing—Bupropion—obesity	0.000527	0.00486	CcSEcCtD
Fluocinolone Acetonide—Eczema—Orlistat—obesity	0.000519	0.00479	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Cimetidine—obesity	0.000517	0.00477	CcSEcCtD
Fluocinolone Acetonide—NR3C1—digestive system—obesity	0.000517	0.02	CbGeAlD
Fluocinolone Acetonide—Hypersensitivity—Methamphetamine—obesity	0.000515	0.00475	CcSEcCtD
Fluocinolone Acetonide—Gastroenteritis—Sibutramine—obesity	0.00051	0.0047	CcSEcCtD
Fluocinolone Acetonide—Photophobia—Bupropion—obesity	0.000509	0.0047	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Diethylpropion—obesity	0.000504	0.00465	CcSEcCtD
Fluocinolone Acetonide—Eczema—Sibutramine—obesity	0.000503	0.00464	CcSEcCtD
Fluocinolone Acetonide—Oedema—Phentermine—obesity	0.000502	0.00463	CcSEcCtD
Fluocinolone Acetonide—Dry eye—Bupropion—obesity	0.000501	0.00462	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Sibutramine—obesity	0.0005	0.00462	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Benzphetamine—obesity	0.000496	0.00458	CcSEcCtD
Fluocinolone Acetonide—NR3C1—adrenal gland—obesity	0.000492	0.0191	CbGeAlD
Fluocinolone Acetonide—Hypoglycaemia—Orlistat—obesity	0.000478	0.00441	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Methamphetamine—obesity	0.000478	0.00441	CcSEcCtD
Fluocinolone Acetonide—Mania—Topiramate—obesity	0.000475	0.00438	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Sibutramine—obesity	0.000463	0.00427	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Methamphetamine—obesity	0.000462	0.00426	CcSEcCtD
Fluocinolone Acetonide—Ear pain—Bupropion—obesity	0.000462	0.00426	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Benzphetamine—obesity	0.000461	0.00425	CcSEcCtD
Fluocinolone Acetonide—Glaucoma—Topiramate—obesity	0.000459	0.00424	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Sibutramine—obesity	0.000452	0.00417	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Benzphetamine—obesity	0.000446	0.00411	CcSEcCtD
Fluocinolone Acetonide—Gastroenteritis—Bupropion—obesity	0.000444	0.0041	CcSEcCtD
Fluocinolone Acetonide—Otitis media—Topiramate—obesity	0.000444	0.0041	CcSEcCtD
Fluocinolone Acetonide—Eczema—Bupropion—obesity	0.000438	0.00404	CcSEcCtD
Fluocinolone Acetonide—Headache—Methamphetamine—obesity	0.000438	0.00404	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Bupropion—obesity	0.000436	0.00402	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Cimetidine—obesity	0.000433	0.004	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Phentermine—obesity	0.000433	0.004	CcSEcCtD
Fluocinolone Acetonide—NR3C1—endocrine gland—obesity	0.000427	0.0165	CbGeAlD
Fluocinolone Acetonide—Rhinorrhoea—Topiramate—obesity	0.000427	0.00394	CcSEcCtD
Fluocinolone Acetonide—Headache—Benzphetamine—obesity	0.000422	0.00389	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Phendimetrazine—obesity	0.00042	0.00388	CcSEcCtD
Fluocinolone Acetonide—Visual disturbance—Bupropion—obesity	0.000416	0.00383	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Phendimetrazine—obesity	0.000406	0.00375	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Bupropion—obesity	0.000404	0.00372	CcSEcCtD
Fluocinolone Acetonide—Influenza—Orlistat—obesity	0.000403	0.00372	CcSEcCtD
Fluocinolone Acetonide—Nausea—Benzphetamine—obesity	0.0004	0.00369	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Diethylpropion—obesity	0.000398	0.00367	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Bupropion—obesity	0.000394	0.00363	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Bupropion—obesity	0.000394	0.00363	CcSEcCtD
Fluocinolone Acetonide—Influenza—Sibutramine—obesity	0.00039	0.0036	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Phenylpropanolamine—obesity	0.000387	0.00357	CcSEcCtD
Fluocinolone Acetonide—NR3C1—liver—obesity	0.000385	0.0149	CbGeAlD
Fluocinolone Acetonide—Headache—Phendimetrazine—obesity	0.000385	0.00355	CcSEcCtD
Fluocinolone Acetonide—Viral infection—Topiramate—obesity	0.000383	0.00353	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Cimetidine—obesity	0.000379	0.00349	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Diethylpropion—obesity	0.000377	0.00348	CcSEcCtD
Fluocinolone Acetonide—Lacrimation increased—Topiramate—obesity	0.000375	0.00346	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Orlistat—obesity	0.000375	0.00346	CcSEcCtD
Fluocinolone Acetonide—Nausea—Phendimetrazine—obesity	0.000365	0.00337	CcSEcCtD
Fluocinolone Acetonide—Infestation—Orlistat—obesity	0.00036	0.00332	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Orlistat—obesity	0.00036	0.00332	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Bupropion—obesity	0.000352	0.00325	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Phenylpropanolamine—obesity	0.000347	0.0032	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Phentermine—obesity	0.000343	0.00317	CcSEcCtD
Fluocinolone Acetonide—Influenza—Bupropion—obesity	0.00034	0.00314	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Orlistat—obesity	0.000337	0.00311	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Phenylpropanolamine—obesity	0.000334	0.00308	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Phentermine—obesity	0.000332	0.00306	CcSEcCtD
Fluocinolone Acetonide—Rash—Phenylpropanolamine—obesity	0.000331	0.00305	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Phenylpropanolamine—obesity	0.00033	0.00305	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Cimetidine—obesity	0.000328	0.00303	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Sibutramine—obesity	0.000327	0.00301	CcSEcCtD
Fluocinolone Acetonide—Photophobia—Topiramate—obesity	0.000325	0.00299	CcSEcCtD
Fluocinolone Acetonide—Dry eye—Topiramate—obesity	0.000319	0.00295	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Phentermine—obesity	0.000319	0.00294	CcSEcCtD
Fluocinolone Acetonide—Rash—Phentermine—obesity	0.000317	0.00292	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Bupropion—obesity	0.000316	0.00292	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Phentermine—obesity	0.000316	0.00292	CcSEcCtD
Fluocinolone Acetonide—Headache—Phentermine—obesity	0.000314	0.0029	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Sibutramine—obesity	0.000313	0.00289	CcSEcCtD
Fluocinolone Acetonide—Nausea—Phenylpropanolamine—obesity	0.000312	0.00287	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Cimetidine—obesity	0.000306	0.00282	CcSEcCtD
Fluocinolone Acetonide—Infestation—Bupropion—obesity	0.000303	0.0028	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Bupropion—obesity	0.000303	0.0028	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Sibutramine—obesity	0.000301	0.00278	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Diethylpropion—obesity	0.000299	0.00276	CcSEcCtD
Fluocinolone Acetonide—Nausea—Phentermine—obesity	0.000298	0.00275	CcSEcCtD
Fluocinolone Acetonide—Ear pain—Topiramate—obesity	0.000294	0.00271	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Sibutramine—obesity	0.000292	0.00269	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Orlistat—obesity	0.000291	0.00269	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Diethylpropion—obesity	0.000289	0.00266	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Orlistat—obesity	0.000285	0.00263	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Bupropion—obesity	0.000285	0.00263	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Cimetidine—obesity	0.000284	0.00262	CcSEcCtD
Fluocinolone Acetonide—Gastroenteritis—Topiramate—obesity	0.000283	0.00261	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Orlistat—obesity	0.000283	0.00261	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Orlistat—obesity	0.000281	0.00259	CcSEcCtD
Fluocinolone Acetonide—Eczema—Topiramate—obesity	0.000279	0.00258	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Topiramate—obesity	0.000278	0.00256	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Diethylpropion—obesity	0.000278	0.00256	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Sibutramine—obesity	0.000276	0.00255	CcSEcCtD
Fluocinolone Acetonide—Rash—Diethylpropion—obesity	0.000275	0.00254	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Orlistat—obesity	0.000275	0.00254	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Diethylpropion—obesity	0.000275	0.00254	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Cimetidine—obesity	0.000275	0.00254	CcSEcCtD
Fluocinolone Acetonide—Headache—Diethylpropion—obesity	0.000274	0.00252	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Bupropion—obesity	0.000273	0.00252	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Sibutramine—obesity	0.000272	0.00251	CcSEcCtD
Fluocinolone Acetonide—Back pain—Orlistat—obesity	0.000272	0.00251	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Bupropion—obesity	0.000268	0.00247	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Sibutramine—obesity	0.000266	0.00246	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Orlistat—obesity	0.000265	0.00244	CcSEcCtD
Fluocinolone Acetonide—Visual disturbance—Topiramate—obesity	0.000265	0.00244	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Cimetidine—obesity	0.000264	0.00244	CcSEcCtD
Fluocinolone Acetonide—Back pain—Sibutramine—obesity	0.000263	0.00243	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Bupropion—obesity	0.000263	0.00242	CcSEcCtD
Fluocinolone Acetonide—Rash—Cimetidine—obesity	0.000262	0.00242	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Cimetidine—obesity	0.000262	0.00242	CcSEcCtD
Fluocinolone Acetonide—Headache—Cimetidine—obesity	0.00026	0.0024	CcSEcCtD
Fluocinolone Acetonide—Nausea—Diethylpropion—obesity	0.000259	0.00239	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Topiramate—obesity	0.000257	0.00237	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Sibutramine—obesity	0.000256	0.00237	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Bupropion—obesity	0.000255	0.00235	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Orlistat—obesity	0.000253	0.00233	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Topiramate—obesity	0.000251	0.00231	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Topiramate—obesity	0.000251	0.00231	CcSEcCtD
Fluocinolone Acetonide—Nausea—Cimetidine—obesity	0.000247	0.00228	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Bupropion—obesity	0.000246	0.00227	CcSEcCtD
Fluocinolone Acetonide—Cough—Orlistat—obesity	0.000245	0.00226	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Sibutramine—obesity	0.000244	0.00226	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Bupropion—obesity	0.000241	0.00222	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Bupropion—obesity	0.000239	0.0022	CcSEcCtD
Fluocinolone Acetonide—Cough—Sibutramine—obesity	0.000237	0.00219	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Bupropion—obesity	0.000237	0.00219	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Bupropion—obesity	0.000232	0.00214	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Sibutramine—obesity	0.000232	0.00214	CcSEcCtD
Fluocinolone Acetonide—Oedema—Orlistat—obesity	0.000229	0.00212	CcSEcCtD
Fluocinolone Acetonide—Back pain—Bupropion—obesity	0.000229	0.00212	CcSEcCtD
Fluocinolone Acetonide—Infection—Orlistat—obesity	0.000228	0.0021	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Orlistat—obesity	0.000225	0.00208	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Topiramate—obesity	0.000224	0.00207	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Bupropion—obesity	0.000224	0.00206	CcSEcCtD
Fluocinolone Acetonide—Oedema—Sibutramine—obesity	0.000222	0.00205	CcSEcCtD
Fluocinolone Acetonide—Infection—Sibutramine—obesity	0.000221	0.00204	CcSEcCtD
Fluocinolone Acetonide—Difluprednate—NR3C1—obesity	0.000218	0.0484	CrCbGaD
Fluocinolone Acetonide—Vertigo—Bupropion—obesity	0.000213	0.00197	CcSEcCtD
Fluocinolone Acetonide—Clocortolone—NR3C1—obesity	0.000211	0.047	CrCbGaD
Fluocinolone Acetonide—Musculoskeletal discomfort—Orlistat—obesity	0.000209	0.00193	CcSEcCtD
Fluocinolone Acetonide—Cough—Bupropion—obesity	0.000207	0.00191	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Sibutramine—obesity	0.000202	0.00187	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Bupropion—obesity	0.000202	0.00186	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Topiramate—obesity	0.000202	0.00186	CcSEcCtD
Fluocinolone Acetonide—Desonide—NR3C1—obesity	0.0002	0.0445	CrCbGaD
Fluocinolone Acetonide—Diflorasone—NR3C1—obesity	0.0002	0.0445	CrCbGaD
Fluocinolone Acetonide—Gastrointestinal disorder—Orlistat—obesity	0.000198	0.00183	CcSEcCtD
Fluocinolone Acetonide—Pain—Orlistat—obesity	0.000196	0.00181	CcSEcCtD
Fluocinolone Acetonide—Desoximetasone—NR3C1—obesity	0.000195	0.0434	CrCbGaD
Fluocinolone Acetonide—Oedema—Bupropion—obesity	0.000194	0.00179	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Topiramate—obesity	0.000193	0.00178	CcSEcCtD
Fluocinolone Acetonide—Infestation—Topiramate—obesity	0.000193	0.00178	CcSEcCtD
Fluocinolone Acetonide—Infection—Bupropion—obesity	0.000192	0.00177	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Sibutramine—obesity	0.000192	0.00177	CcSEcCtD
Fluocinolone Acetonide—Fludrocortisone—AR—obesity	0.00019	0.0422	CrCbGaD
Fluocinolone Acetonide—Pain—Sibutramine—obesity	0.00019	0.00175	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Bupropion—obesity	0.00019	0.00175	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Topiramate—obesity	0.000181	0.00167	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Orlistat—obesity	0.000181	0.00167	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Bupropion—obesity	0.000176	0.00163	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Sibutramine—obesity	0.000176	0.00162	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Topiramate—obesity	0.000174	0.00161	CcSEcCtD
Fluocinolone Acetonide—Flurandrenolide—NR3C1—obesity	0.000171	0.038	CrCbGaD
Fluocinolone Acetonide—Connective tissue disorder—Topiramate—obesity	0.000171	0.00157	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Orlistat—obesity	0.000169	0.00156	CcSEcCtD
Fluocinolone Acetonide—Flumethasone Pivalate—NR3C1—obesity	0.000168	0.0373	CrCbGaD
Fluocinolone Acetonide—Visual impairment—Topiramate—obesity	0.000167	0.00154	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Bupropion—obesity	0.000167	0.00154	CcSEcCtD
Fluocinolone Acetonide—Pain—Bupropion—obesity	0.000166	0.00153	CcSEcCtD
Fluocinolone Acetonide—Halobetasol Propionate—NR3C1—obesity	0.000165	0.0367	CrCbGaD
Fluocinolone Acetonide—Hypersensitivity—Sibutramine—obesity	0.000164	0.00151	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Orlistat—obesity	0.000162	0.0015	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Topiramate—obesity	0.000162	0.0015	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Sibutramine—obesity	0.000157	0.00145	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Orlistat—obesity	0.000157	0.00145	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Topiramate—obesity	0.000156	0.00144	CcSEcCtD
Fluocinolone Acetonide—Amcinonide—NR3C1—obesity	0.000153	0.0341	CrCbGaD
Fluocinolone Acetonide—Budesonide—NR3C1—obesity	0.000153	0.0341	CrCbGaD
Fluocinolone Acetonide—Alopecia—Topiramate—obesity	0.000153	0.00142	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Bupropion—obesity	0.000153	0.00141	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Topiramate—obesity	0.000152	0.0014	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Sibutramine—obesity	0.000152	0.0014	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Orlistat—obesity	0.000152	0.0014	CcSEcCtD
Fluocinolone Acetonide—Erythema—Topiramate—obesity	0.000151	0.00139	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Topiramate—obesity	0.000151	0.00139	CcSEcCtD
Fluocinolone Acetonide—Fluticasone furoate—NR3C1—obesity	0.00015	0.0335	CrCbGaD
Fluocinolone Acetonide—Dysgeusia—Topiramate—obesity	0.000148	0.00137	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Sibutramine—obesity	0.000147	0.00135	CcSEcCtD
Fluocinolone Acetonide—Back pain—Topiramate—obesity	0.000146	0.00135	CcSEcCtD
Fluocinolone Acetonide—Mometasone—NR3C1—obesity	0.000146	0.0325	CrCbGaD
Fluocinolone Acetonide—Vomiting—Orlistat—obesity	0.000146	0.00135	CcSEcCtD
Fluocinolone Acetonide—Rash—Orlistat—obesity	0.000145	0.00133	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Orlistat—obesity	0.000145	0.00133	CcSEcCtD
Fluocinolone Acetonide—Rimexolone—NR3C1—obesity	0.000144	0.0321	CrCbGaD
Fluocinolone Acetonide—Headache—Orlistat—obesity	0.000144	0.00133	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Bupropion—obesity	0.000143	0.00132	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Topiramate—obesity	0.000142	0.00131	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Sibutramine—obesity	0.000141	0.0013	CcSEcCtD
Fluocinolone Acetonide—Rash—Sibutramine—obesity	0.00014	0.00129	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Sibutramine—obesity	0.00014	0.00129	CcSEcCtD
Fluocinolone Acetonide—Headache—Sibutramine—obesity	0.000139	0.00128	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Bupropion—obesity	0.000137	0.00126	CcSEcCtD
Fluocinolone Acetonide—Nausea—Orlistat—obesity	0.000136	0.00126	CcSEcCtD
Fluocinolone Acetonide—Beclomethasone—NR3C1—obesity	0.000136	0.0303	CrCbGaD
Fluocinolone Acetonide—Fluocinonide—NR3C1—obesity	0.000136	0.0303	CrCbGaD
Fluocinolone Acetonide—Vertigo—Topiramate—obesity	0.000136	0.00125	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Bupropion—obesity	0.000132	0.00122	CcSEcCtD
Fluocinolone Acetonide—Alclometasone—NR3C1—obesity	0.000132	0.0294	CrCbGaD
Fluocinolone Acetonide—Nausea—Sibutramine—obesity	0.000132	0.00122	CcSEcCtD
Fluocinolone Acetonide—Cough—Topiramate—obesity	0.000132	0.00122	CcSEcCtD
Fluocinolone Acetonide—Flunisolide—NR3C1—obesity	0.000129	0.0286	CrCbGaD
Fluocinolone Acetonide—Clobetasol propionate—NR3C1—obesity	0.000129	0.0286	CrCbGaD
Fluocinolone Acetonide—Fludrocortisone—NR3C1—obesity	0.000129	0.0286	CrCbGaD
Fluocinolone Acetonide—Arthralgia—Topiramate—obesity	0.000129	0.00119	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Bupropion—obesity	0.000128	0.00118	CcSEcCtD
Fluocinolone Acetonide—Paramethasone—NR3C1—obesity	0.000127	0.0283	CrCbGaD
Fluocinolone Acetonide—Triamcinolone—BCHE—obesity	0.000125	0.0277	CrCbGaD
Fluocinolone Acetonide—Fluorometholone—NR3C1—obesity	0.000124	0.0276	CrCbGaD
Fluocinolone Acetonide—Oedema—Topiramate—obesity	0.000123	0.00114	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Bupropion—obesity	0.000123	0.00114	CcSEcCtD
Fluocinolone Acetonide—Infection—Topiramate—obesity	0.000123	0.00113	CcSEcCtD
Fluocinolone Acetonide—Rash—Bupropion—obesity	0.000122	0.00113	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Bupropion—obesity	0.000122	0.00112	CcSEcCtD
Fluocinolone Acetonide—Headache—Bupropion—obesity	0.000121	0.00112	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Topiramate—obesity	0.000121	0.00112	CcSEcCtD
Fluocinolone Acetonide—Methylprednisolone—NR3C1—obesity	0.00012	0.0267	CrCbGaD
Fluocinolone Acetonide—Nausea—Bupropion—obesity	0.000115	0.00106	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Topiramate—obesity	0.000112	0.00104	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Topiramate—obesity	0.000106	0.000982	CcSEcCtD
Fluocinolone Acetonide—Pain—Topiramate—obesity	0.000105	0.000973	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—CYP19A1—obesity	0.000102	0.0227	CrCbGaD
Fluocinolone Acetonide—Triamcinolone—NR3C1—obesity	0.000101	0.0225	CrCbGaD
Fluocinolone Acetonide—Body temperature increased—Topiramate—obesity	9.75e-05	0.000899	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Topiramate—obesity	9.09e-05	0.000838	CcSEcCtD
Fluocinolone Acetonide—Fluticasone Propionate—NR3C1—obesity	9.04e-05	0.0201	CrCbGaD
Fluocinolone Acetonide—Pruritus—Topiramate—obesity	8.72e-05	0.000805	CcSEcCtD
Fluocinolone Acetonide—Prednisolone—NR3C1—obesity	8.46e-05	0.0188	CrCbGaD
Fluocinolone Acetonide—Diarrhoea—Topiramate—obesity	8.44e-05	0.000778	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—NR3C1—obesity	8.29e-05	0.0184	CrCbGaD
Fluocinolone Acetonide—Dizziness—Topiramate—obesity	8.15e-05	0.000752	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Topiramate—obesity	7.84e-05	0.000723	CcSEcCtD
Fluocinolone Acetonide—Rash—Topiramate—obesity	7.78e-05	0.000717	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Topiramate—obesity	7.77e-05	0.000717	CcSEcCtD
Fluocinolone Acetonide—Headache—Topiramate—obesity	7.73e-05	0.000713	CcSEcCtD
Fluocinolone Acetonide—Nausea—Topiramate—obesity	7.32e-05	0.000676	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP19A1—obesity	5.95e-05	0.0132	CrCbGaD
Fluocinolone Acetonide—Triamcinolone—PTGS2—obesity	5.74e-05	0.0128	CrCbGaD
Fluocinolone Acetonide—Dexamethasone—NR3C1—obesity	4.82e-05	0.0107	CrCbGaD
Fluocinolone Acetonide—Betamethasone—PTGS2—obesity	4.7e-05	0.0105	CrCbGaD
Fluocinolone Acetonide—Dexamethasone—CYP2E1—obesity	4.44e-05	0.00987	CrCbGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—AR—obesity	3.48e-05	0.000468	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—obesity	3.46e-05	0.000465	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MC4R—obesity	3.44e-05	0.000464	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NPY2R—obesity	3.44e-05	0.000464	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MC3R—obesity	3.44e-05	0.000464	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NPY1R—obesity	3.44e-05	0.000464	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—obesity	3.44e-05	0.000463	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—G6PD—obesity	3.41e-05	0.000459	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—obesity	3.41e-05	0.000459	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TGFB1—obesity	3.39e-05	0.000457	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PPY—obesity	3.38e-05	0.000455	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SREBF2—obesity	3.37e-05	0.000454	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HK1—obesity	3.37e-05	0.000454	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CD36—obesity	3.37e-05	0.000453	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—NPS—obesity	3.35e-05	0.000451	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKCH—obesity	3.32e-05	0.000446	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HDAC8—obesity	3.32e-05	0.000446	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GIP—obesity	3.32e-05	0.000446	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—obesity	3.29e-05	0.000443	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HTR2C—obesity	3.28e-05	0.000442	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—DRD1—obesity	3.28e-05	0.000442	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LPA—obesity	3.26e-05	0.000438	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CAV1—obesity	3.23e-05	0.000435	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—APOA1—obesity	3.23e-05	0.000434	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NR1I2—obesity	3.19e-05	0.000429	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LPIN1—obesity	3.19e-05	0.000429	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ADRB1—obesity	3.18e-05	0.000428	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TNF—obesity	3.17e-05	0.000426	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LEPR—obesity	3.15e-05	0.000424	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—obesity	3.14e-05	0.000422	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PPARA—obesity	3.13e-05	0.000421	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOA5—obesity	3.12e-05	0.00042	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GHRL—obesity	3.11e-05	0.000419	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—DRD4—obesity	3.09e-05	0.000416	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—F2—obesity	3.08e-05	0.000414	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PRKCB—obesity	3.08e-05	0.000414	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—AGT—obesity	3.03e-05	0.000408	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	3e-05	0.000404	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CLOCK—obesity	2.98e-05	0.000401	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC22A1—obesity	2.98e-05	0.000401	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—obesity	2.97e-05	0.0004	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CNR1—obesity	2.95e-05	0.000397	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CG—obesity	2.95e-05	0.000396	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CAV1—obesity	2.94e-05	0.000396	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOA1—obesity	2.94e-05	0.000395	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SULT2A1—obesity	2.9e-05	0.000391	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GLP1R—obesity	2.9e-05	0.000391	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—DRD2—obesity	2.88e-05	0.000387	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—DPYD—obesity	2.86e-05	0.000384	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GCG—obesity	2.85e-05	0.000383	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADRB3—obesity	2.82e-05	0.000379	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GAL—obesity	2.75e-05	0.000371	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PRKAR2B—obesity	2.75e-05	0.00037	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—TNF—obesity	2.74e-05	0.000368	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—PTGS2—obesity	2.74e-05	0.00608	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—DCN—obesity	2.73e-05	0.000367	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—C5AR1—obesity	2.72e-05	0.000366	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IGF1—obesity	2.7e-05	0.000363	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT2—obesity	2.69e-05	0.000363	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—obesity	2.68e-05	0.000361	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—obesity	2.67e-05	0.000359	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CPT1A—obesity	2.65e-05	0.000357	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—PPARA—obesity	2.64e-05	0.000355	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NAMPT—obesity	2.6e-05	0.00035	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CD—obesity	2.59e-05	0.000348	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—obesity	2.59e-05	0.000348	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LIPC—obesity	2.59e-05	0.000348	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GCK—obesity	2.59e-05	0.000348	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ADRB2—obesity	2.58e-05	0.000347	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOC3—obesity	2.57e-05	0.000346	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SERPINE1—obesity	2.56e-05	0.000345	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—IL6—obesity	2.56e-05	0.000344	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—ALB—obesity	2.56e-05	0.000344	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—obesity	2.55e-05	0.000343	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CETP—obesity	2.5e-05	0.000336	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKG1—obesity	2.49e-05	0.000335	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCK—obesity	2.49e-05	0.000335	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—RHOA—obesity	2.47e-05	0.000332	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SDC1—obesity	2.47e-05	0.000332	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GNB3—obesity	2.45e-05	0.00033	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—obesity	2.45e-05	0.00033	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NOS3—obesity	2.44e-05	0.000329	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3R1—obesity	2.44e-05	0.000329	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKR1C3—obesity	2.43e-05	0.000327	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RBP4—obesity	2.43e-05	0.000327	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GLP1R—obesity	2.43e-05	0.000327	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SCARB1—obesity	2.39e-05	0.000322	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GNAS—obesity	2.39e-05	0.000322	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—ESR1—obesity	2.39e-05	0.000321	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCKAR—obesity	2.39e-05	0.000321	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HRH3—obesity	2.39e-05	0.000321	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CD—obesity	2.36e-05	0.000317	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—obesity	2.33e-05	0.000313	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SREBF1—obesity	2.32e-05	0.000312	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKAR2B—obesity	2.3e-05	0.000309	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCL5—obesity	2.29e-05	0.000308	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GOT2—obesity	2.26e-05	0.000304	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CB—obesity	2.26e-05	0.000304	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3R1—obesity	2.23e-05	0.0003	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NCF2—obesity	2.22e-05	0.000299	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL6—obesity	2.21e-05	0.000297	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—FASN—obesity	2.21e-05	0.000297	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—BCHE—obesity	2.2e-05	0.000296	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—obesity	2.18e-05	0.000293	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—PPARG—obesity	2.18e-05	0.000293	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NPY—obesity	2.16e-05	0.000291	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IAPP—obesity	2.15e-05	0.000289	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOC3—obesity	2.15e-05	0.000289	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP2E1—obesity	2.12e-05	0.000286	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NQO1—obesity	2.1e-05	0.000282	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CRH—obesity	2.09e-05	0.000281	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HTR1B—obesity	2.09e-05	0.000281	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SDC1—obesity	2.06e-05	0.000278	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PRKCD—obesity	2.06e-05	0.000277	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CB—obesity	2.05e-05	0.000276	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.04e-05	0.000274	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKR1C3—obesity	2.03e-05	0.000273	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HTR2A—obesity	2.01e-05	0.000271	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—C3—obesity	2.01e-05	0.000271	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GCG—obesity	2.01e-05	0.000271	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC2A4—obesity	2.01e-05	0.000271	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PARP1—obesity	2e-05	0.000269	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYCS—obesity	1.99e-05	0.000267	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NPS—obesity	1.98e-05	0.000266	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—SERPINE1—obesity	1.96e-05	0.000264	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GOT1—obesity	1.95e-05	0.000262	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GGT1—obesity	1.95e-05	0.000262	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HTR2C—obesity	1.94e-05	0.000261	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—DRD1—obesity	1.94e-05	0.000261	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NCOA1—obesity	1.92e-05	0.000258	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AGT—obesity	1.91e-05	0.000257	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ESR2—obesity	1.9e-05	0.000255	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—STK11—obesity	1.89e-05	0.000255	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP19A1—obesity	1.89e-05	0.000255	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NTRK2—obesity	1.89e-05	0.000254	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADRB1—obesity	1.88e-05	0.000253	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PARP1—obesity	1.84e-05	0.000248	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GHRL—obesity	1.84e-05	0.000248	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—DRD4—obesity	1.82e-05	0.000245	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—F2—obesity	1.77e-05	0.000238	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PRKCB—obesity	1.77e-05	0.000238	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—COMT—obesity	1.76e-05	0.000237	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NCOA1—obesity	1.75e-05	0.000235	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CNR1—obesity	1.74e-05	0.000234	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GNB3—obesity	1.73e-05	0.000233	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPARGC1A—obesity	1.73e-05	0.000233	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HMOX1—obesity	1.73e-05	0.000232	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TCF7L2—obesity	1.71e-05	0.00023	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—DRD2—obesity	1.7e-05	0.000229	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CG—obesity	1.69e-05	0.000227	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GNAS—obesity	1.69e-05	0.000227	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GCG—obesity	1.68e-05	0.000226	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTPN1—obesity	1.68e-05	0.000226	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AR—obesity	1.67e-05	0.000225	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOB—obesity	1.65e-05	0.000222	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TGFB1—obesity	1.62e-05	0.000218	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—POMC—obesity	1.61e-05	0.000217	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRL—obesity	1.6e-05	0.000216	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STK11—obesity	1.58e-05	0.000213	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LPL—obesity	1.58e-05	0.000212	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCL2—obesity	1.57e-05	0.000212	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PLG—obesity	1.56e-05	0.00021	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT2—obesity	1.55e-05	0.000208	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GPX1—obesity	1.54e-05	0.000207	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SIRT1—obesity	1.53e-05	0.000205	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FOXO3—obesity	1.53e-05	0.000205	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADRB2—obesity	1.52e-05	0.000205	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CD36—obesity	1.5e-05	0.000202	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SOCS1—obesity	1.5e-05	0.000202	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CD—obesity	1.49e-05	0.0002	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SOCS3—obesity	1.48e-05	0.000199	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GNB3—obesity	1.45e-05	0.000195	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—TYK2—obesity	1.43e-05	0.000192	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF2—obesity	1.42e-05	0.000192	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MTHFR—obesity	1.42e-05	0.000191	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—RHOA—obesity	1.42e-05	0.000191	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GNAS—obesity	1.41e-05	0.00019	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3R1—obesity	1.4e-05	0.000189	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPARA—obesity	1.39e-05	0.000188	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOB—obesity	1.38e-05	0.000186	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CA—obesity	1.38e-05	0.000185	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AGT—obesity	1.35e-05	0.000182	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL5—obesity	1.35e-05	0.000182	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PRKCD—obesity	1.32e-05	0.000178	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOE—obesity	1.32e-05	0.000178	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LPL—obesity	1.32e-05	0.000178	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CAV1—obesity	1.31e-05	0.000176	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FOXO1—obesity	1.31e-05	0.000176	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RPS6KB1—obesity	1.31e-05	0.000176	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOA1—obesity	1.31e-05	0.000176	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CB—obesity	1.3e-05	0.000174	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PPARA—obesity	1.27e-05	0.000171	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.25e-05	0.000169	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—MYC—obesity	1.24e-05	0.000167	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKCD—obesity	1.22e-05	0.000164	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CG—obesity	1.19e-05	0.000161	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HTR2A—obesity	1.19e-05	0.00016	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—C3—obesity	1.19e-05	0.00016	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPARG—obesity	1.15e-05	0.000155	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ESR1—obesity	1.15e-05	0.000155	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—POMC—obesity	1.14e-05	0.000153	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IRS2—obesity	1.13e-05	0.000152	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—INS—obesity	1.13e-05	0.000152	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AGT—obesity	1.13e-05	0.000152	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT1—obesity	1.12e-05	0.000151	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOE—obesity	1.11e-05	0.000149	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LEP—obesity	1.11e-05	0.000149	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CAV1—obesity	1.1e-05	0.000148	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOA1—obesity	1.09e-05	0.000147	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ESR1—obesity	1.06e-05	0.000142	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CD—obesity	1.05e-05	0.000141	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PPARG—obesity	1.05e-05	0.000141	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—F2—obesity	1.04e-05	0.00014	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKCB—obesity	1.04e-05	0.00014	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALB—obesity	1.04e-05	0.000139	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BAD—obesity	1.03e-05	0.000139	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CG—obesity	9.99e-06	0.000134	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NOS3—obesity	9.91e-06	0.000133	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3R1—obesity	9.91e-06	0.000133	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IRS1—obesity	9.87e-06	0.000133	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—POMC—obesity	9.5e-06	0.000128	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—INS—obesity	9.45e-06	0.000127	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SERPINE1—obesity	9.45e-06	0.000127	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL2—obesity	9.3e-06	0.000125	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CB—obesity	9.15e-06	0.000123	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF1—obesity	9.14e-06	0.000123	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT2—obesity	9.14e-06	0.000123	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS2—obesity	9.07e-06	0.000122	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CD—obesity	8.78e-06	0.000118	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SERPINE1—obesity	8.68e-06	0.000117	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TYK2—obesity	8.44e-06	0.000114	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RHOA—obesity	8.38e-06	0.000113	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3R1—obesity	8.29e-06	0.000112	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOS3—obesity	8.29e-06	0.000112	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CA—obesity	7.9e-06	0.000106	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MTOR—obesity	7.65e-06	0.000103	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CB—obesity	7.65e-06	0.000103	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6—obesity	6.99e-06	9.41e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MMP9—obesity	6.65e-06	8.95e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK8—obesity	6.47e-06	8.7e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT1—obesity	6.45e-06	8.68e-05	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MYC—obesity	5.98e-06	8.05e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STAT3—obesity	5.91e-06	7.96e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CA—obesity	5.58e-06	7.51e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MYC—obesity	5.49e-06	7.39e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TGFB1—obesity	5.48e-06	7.38e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CA—obesity	4.66e-06	6.28e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKT1—obesity	4.56e-06	6.13e-05	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AKT1—obesity	4.15e-06	5.58e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6—obesity	4.13e-06	5.56e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT1—obesity	3.81e-06	5.13e-05	CbGpPWpGaD
